(ATTBF - ABATTIS BIOCEUTICALS CORP)

company profile

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Abattis Bioceuticals (ATTBF) is trading at 0.000001

Open Price
0.000001
Previous close
0.000001
Previous close
0.000001
P/E Ratio
0
Sector
Health Care
Shares outstanding
477804139
Primary exchange
OTC Markets
ISIN
CA00258G1037